Hsbc Holdings PLC lowered its position in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 31.6% in the first quarter, HoldingsChannel reports. The firm owned 132,159 shares of the company’s stock after selling 60,945 shares during the period. Hsbc Holdings PLC’s holdings in Molina Healthcare were worth $17,796,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AQR Capital Management LLC boosted its holdings in Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after purchasing an additional 2,008,458 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Molina Healthcare by 10.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock worth $376,831,000 after buying an additional 201,772 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Molina Healthcare by 24.2% during the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after buying an additional 329,679 shares during the last quarter. Victory Capital Management Inc. raised its position in shares of Molina Healthcare by 46.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock valued at $244,796,000 after buying an additional 447,078 shares during the period. Finally, 8 Knots Management LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter valued at approximately $198,942,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Molina Healthcare Stock Performance
NYSE:MOH opened at $226.74 on Wednesday. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $244.89. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The company has a 50 day moving average price of $205.04 and a 200 day moving average price of $176.37. The stock has a market capitalization of $11.81 billion, a P/E ratio of 67.08 and a beta of 0.74.
Analysts Set New Price Targets
Several research analysts recently weighed in on the company. Jefferies Financial Group set a $230.00 price objective on Molina Healthcare in a research report on Tuesday, July 14th. UBS Group lifted their target price on Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday, May 22nd. Wells Fargo & Company upped their price target on Molina Healthcare from $159.00 to $235.00 and gave the company an “equal weight” rating in a research note on Monday, July 13th. Royal Bank Of Canada increased their price target on Molina Healthcare from $216.00 to $248.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Finally, Sanford C. Bernstein set a $286.00 price objective on Molina Healthcare in a research report on Monday, July 13th. Three equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and an average price target of $207.06.
Check Out Our Latest Stock Analysis on MOH
Insiders Place Their Bets
In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.44% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
